These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 16109139

  • 1. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 2. [The mechanisms of parathyroid hyperplasia and its regression].
    Tokumoto M, Taniguchi M.
    Clin Calcium; 2007 May; 17(5):665-76. PubMed ID: 17470994
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract] [Full Text] [Related]

  • 5. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 6. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM, Beto J.
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [Abstract] [Full Text] [Related]

  • 7. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism.
    Rodriguez M, Nemeth E, Martin D.
    Am J Physiol Renal Physiol; 2005 Feb; 288(2):F253-64. PubMed ID: 15507543
    [Abstract] [Full Text] [Related]

  • 8. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H, Kinugasa E.
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [Abstract] [Full Text] [Related]

  • 9. [Basic and clinical aspects of calcimimetics. Effect of direct injection therapy in the expression of calcium-sensing receptor in parathyroid cell].
    Shiizaki K, Tozawa R, Kusano E.
    Clin Calcium; 2008 Jan; 18(1):51-6. PubMed ID: 18175872
    [Abstract] [Full Text] [Related]

  • 10. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Jan; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism.
    Weber K, Bergow C, Hirmer S, Schüler C, Erben RG.
    J Bone Miner Res; 2009 Jan; 24(1):22-32. PubMed ID: 18767932
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 13. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [Abstract] [Full Text] [Related]

  • 14. The genetic background of uremic secondary hyperparathyroidism.
    Aucella F, Morrone L, Stallone C, Gesualdo L.
    J Nephrol; 2005 May; 18(5):537-47. PubMed ID: 16299679
    [Abstract] [Full Text] [Related]

  • 15. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Gene therapy for secondary hyperparathyroidism].
    Kanai G, Fukagawa M.
    Clin Calcium; 2010 Jul; 20(7):1052-9. PubMed ID: 20585184
    [Abstract] [Full Text] [Related]

  • 16. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S, Aguilera-Tejero E, Bas A, Estepa JC, Lopez I, Madueño JA, Rodriguez M.
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [Abstract] [Full Text] [Related]

  • 17. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 18. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.
    Kidney Blood Press Res; 2013 Oct; 37(1):84-94. PubMed ID: 23552627
    [Abstract] [Full Text] [Related]

  • 19. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
    Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R.
    Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M.
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii9-12. PubMed ID: 12771291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.